Literature DB >> 20472137

The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence.

Michael J Glass1.   

Abstract

Activation of ionotropic N-methyl-D-aspartate (NMDA)-type glutamate receptors in limbic system nuclei, such as the central nucleus of the amygdala (CeA), plays an essential role in autonomic, behavioral, and affective processes that are profoundly impacted by exposure to opioids. However, the heterogeneous ultrastructural distribution of the NMDA receptor, its complex pharmacology, and the paucity of genetic models have hampered the development of linkages between functional amygdala NMDA receptors and opioid dependence. To overcome these shortcomings, high-resolution imaging and molecular pharmacology were used to (1) Identify the ultrastructural localization of the essential NMDA-NR1 receptor (NR1) subunit and its relationship to the mu-opioid receptor (microOR), the major cellular target of abused opioids like morphine, in the CeA and (2) Determine the effect of CeA NR1 deletion on the physical, and particularly, psychological aspects of opioid dependence. Combined immunogold and immuoperoxidase electron microscopic analysis showed that NR1 was prominently expressed in postsynaptic (i.e., somata, dendrites) locations of CeA neurons, where they were also frequently colocalized with the microOR. A spatial-temporal deletion of NR1 in postsynaptic sites of CeA neurons was produced by local microinjection of a neurotropic recombinant adeno-associated virus (rAAV), expressing the green fluorescent protein (GFP) reporter and Cre recombinase (rAAV-GFP-Cre), in adult "floxed" NR1 (fNR1) mice. Mice with deletion of NR1 in the CeA showed no obvious impairments in sensory, motor, or nociceptive function. In addition, when administered chronic morphine, these mice also displayed an acute physical withdrawal syndrome precipitated by naloxone. However, opioid-dependent CeA NR1 knockout mice failed to exhibit a conditioned place aversion induced by naloxone-precipitated withdrawal. These results indicate that postsynaptic NMDA receptor activity in central amygdala neurons is required for the expression of a learned affective behavior associated with opioid withdrawal. The neurogenetic dissociation of physical and psychological properties of opioid dependence demonstrates the value of combined ultrastructural analysis and molecular pharmacology in clarifying the neurobiological mechanisms subserving opioid-mediated plasticity. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472137      PMCID: PMC4589221          DOI: 10.1016/S0083-6729(10)82008-4

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  111 in total

1.  Localization of renin expressing cells in the brain, by use of a REN-eGFP transgenic model.

Authors:  Julie L Lavoie; Martin D Cassell; Kenneth W Gross; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2004-01-15       Impact factor: 3.107

Review 2.  NMDA receptor function: subunit composition versus spatial distribution.

Authors:  Georg Köhr
Journal:  Cell Tissue Res       Date:  2006-07-22       Impact factor: 5.249

Review 3.  Review. Evidence-based treatments of addiction.

Authors:  Charles P O'Brien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 4.  Cortical pathways to the mammalian amygdala.

Authors:  A J McDonald
Journal:  Prog Neurobiol       Date:  1998-06       Impact factor: 11.685

5.  mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding.

Authors:  A Mansour; C A Fox; R C Thompson; H Akil; S J Watson
Journal:  Brain Res       Date:  1994-04-18       Impact factor: 3.252

Review 6.  Allostasis, amygdala, and anticipatory angst.

Authors:  J Schulkin; B S McEwen; P W Gold
Journal:  Neurosci Biobehav Rev       Date:  1994       Impact factor: 8.989

7.  Evidence for coexistence of enkephalin and glutamate in axon terminals and cellular sites for functional interactions of their receptors in the rat locus coeruleus.

Authors:  E J Van Bockstaele; A Saunders; K G Commons; X B Liu; J Peoples
Journal:  J Comp Neurol       Date:  2000-01-31       Impact factor: 3.215

8.  Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents.

Authors:  B A S Reyes; G Drolet; E J Van Bockstaele
Journal:  J Comp Neurol       Date:  2008-06-01       Impact factor: 3.215

9.  Distribution of pro-opiomelanocortin-derived peptides and enkephalins in the rat central nucleus of the amygdala.

Authors:  T S Gray; M D Cassell; J Z Kiss
Journal:  Brain Res       Date:  1984-07-23       Impact factor: 3.252

10.  Cardiac, neuroendocrine, and behavioral effects of central amygdaloid vasopressinergic and oxytocinergic mechanisms under stress-free conditions in rats.

Authors:  B Roozendaal; G H Schoorlemmer; J M Koolhaas; B Bohus
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

View more
  8 in total

1.  Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  Marc A Beckerman; Michael J Glass
Journal:  Exp Neurol       Date:  2010-10-21       Impact factor: 5.330

2.  Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-D-aspartate receptor 1 splice variants in the amygdala.

Authors:  E M Anderson; J K Neubert; R M Caudle
Journal:  Neuroscience       Date:  2012-08-02       Impact factor: 3.590

3.  The activation of NMDA receptor-ERK pathway in the central amygdala is required for the expression of morphine-conditioned place preference in the rat.

Authors:  Fang Li; Xiao-Sheng Wang; Ru-Ping Dai; Jian-Yi Zhang; Xin-Fu Zhou; Wei Hao; Chang-Qi Li
Journal:  Neurotox Res       Date:  2011-06-17       Impact factor: 3.911

4.  Unraveling glutamate-opioid receptor interactions using high-resolution electron microscopy: implications for addiction-related processes.

Authors:  Jillian L Scavone; Esther Asan; Elisabeth J Van Bockstaele
Journal:  Exp Neurol       Date:  2011-04-01       Impact factor: 5.330

5.  The NMDA-NR1 receptor subunit and the mu-opioid receptor are expressed in somatodendritic compartments of central nucleus of the amygdala neurons projecting to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Michael J Glass
Journal:  Exp Neurol       Date:  2011-12-29       Impact factor: 5.330

Review 6.  The Opioid-Addicted Tetrapartite Synapse.

Authors:  Anna Kruyer; Vivian C Chioma; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2019-06-13       Impact factor: 13.382

7.  Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Tracey A Van Kempen; Nicholas J Justice; Teresa A Milner; Michael J Glass
Journal:  Exp Neurol       Date:  2012-10-12       Impact factor: 5.330

8.  Acute morphine associated alterations in the subcellular location of the AMPA-GluR1 receptor subunit in dendrites of neurons in the mouse central nucleus of the amygdala: comparisons and contrasts with other glutamate receptor subunits.

Authors:  Marc A Beckerman; Evgeny Ogorodnik; Michael J Glass
Journal:  Synapse       Date:  2013-06-08       Impact factor: 2.562

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.